Ascend Wellness Holdings, Inc. (AAWH): AWH Reports Second Quarter 2026 Financial Results
Ascend Wellness Holdings, Inc. (AAWH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AWH Reports Second Quarter 2026 Financial Results Generated Q2 2026 net revenue of $126.1 million and Adjusted EBITDA 1 of $29.1 million Scaled retail footprint to 55 locations, up from 48 at the end of Q1 2026 2 Grew market share by ~5% across our seven markets, ret
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
Traders can update models based on the disclosed Q2 financials and cash position, and price in event risk around the Aug 28 shareholder vote for the reverse stock split tied to a major U.S. exchange uplisting.
Market read
Fresh quarterly numbers plus a concrete corporate-action timeline (reverse split vote) create tradable catalysts for AAWH, beyond a routine earnings recap.
What to watch
The work stoppage impact is described as limited in Q2 but could affect Q3; also, the reverse-split and uplisting are execution-dependent and can introduce uncertainty.
Background
This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting Ascend Wellness Holdings’ Q2 2026 results and related operational updates, including a reverse-split proxy filing for a planned uplisting.
Ticker impact
Ascend Wellness reported Q2 2026 net revenue of $126.1M and Adjusted EBITDA of $29.1M, plus a planned reverse split for a major U.S. exchange uplisting.
Moderately positive bias into the Aug 28 reverse-split vote, with volatility risk around execution and uplisting expectations.
Quarterly results show sequential revenue and Adjusted EBITDA growth, while the reverse-split proxy is a concrete corporate-action catalyst that can affect trading dynamics and investor perception.
Market effects
Supports the narrative of improving operating leverage for vertically integrated multi-state cannabis operators, potentially aiding sector sentiment.
Highlights state-specific regulatory and license-cap changes (Massachusetts) and Ohio expansion via a pending operator transaction.
Limited direct global linkage; primarily impacts U.S. cannabis equities and OTC-to-exchange uplisting expectations.
Counterpoint
Sequential growth may be partially offset by wholesale pricing/volume softness and a recent work stoppage, so the quality of earnings could be less durable than it appears.
Key entities
- companyAscend Wellness Holdings, Inc.
Multi-state vertically integrated cannabis operator and consumer packaged goods company reporting Q2 2026 results and filing a proxy for a reverse stock split.
- regulatorU.S. Drug Enforcement Administration (DEA)
Ascend submitted applications to register certain state-licensed medical cannabis operations under an expedited pathway tied to rescheduling to Schedule III.
- regulatorNew Jersey Cannabis Regulatory Commission
Approved Ascend’s partner store in Marlton subsequent to quarter-end.
